Rozusaf-F 5 combines Rosuvastatin (5 mg) and Fenofibrate (67 mg) to offer a comprehensive approach to lipid management and cardiovascular health. Rosuvastatin effectively lowers LDL (bad cholesterol) and triglycerides while Fenofibrate helps increase HDL (good cholesterol) and further reduce triglyceride levels. This synergistic formulation is ideal for individuals seeking to improve their lipid profiles and minimize the risk of cardiovascular events.
Reviews
There are no reviews yet.